Tumor Time‐Course Predicts Overall Survival in Non‐Small Cell Lung Cancer Patients Treated With Atezolizumab: Dependency on Follow‐Up Time
CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.12489
Full Text
Open PDFAbstract
Available in full text
Date
January 28, 2020
Authors
Publisher
Wiley